Skip to main content
TipRanks
Go Ultimate75% OFF

Attendo AB (7AT) AI Stock Analysis

2 Followers
DE:7AT

Attendo AB

(Frankfurt:7AT)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong revenue growthSustained revenue expansion indicates stronger demand and growing service volumes across Attendo’s care operations. Continued top-line momentum can support operating leverage, improve resource utilization, and provide a durable base for earnings growth over the next several quarters.
Negative Factors
High financial leverageAttendo’s sizable debt relative to equity reduces financial flexibility and leaves less room to absorb weaker operating conditions. Leverage can also constrain future investment and capital allocation, making sustained cash generation especially important for preserving balance-sheet stability.

Attendo AB (7AT) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%60%DE:7AT+55.93%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 18.55B
Dividend Yield
1.54%
Average Volume (3M)
936
Price to Earnings (P/E)
20.0
Beta (1Y)
0.38
Revenue Growth
2.92%
EPS Growth
65.44%
Country
Germany
Employees
33,000
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Attendo AB Business Overview & Revenue Model

Company Description

Founded in 1985 and based in Danderyd, Sweden, Attendo AB (publ) is a prominent provider of publicly financed care services across the Nordic countries, including Sweden, Finland, Norway, and Denmark. The company's extensive service portfolio address...

Attendo AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

DE:7AT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:AMBEASE:AMBEA71OutperformSEK 16.26B18.4816.80%1.36%11.39%30.51%
SE:CARESE:CARE71OutperformSEK 715.19M14.90――12.86%18.01%
SE:ASKERSE:ASKER67NeutralSEK 28.14B37.77―0.52%――
SE:MCOV.BSE:MCOV.B61NeutralSEK 40.35B40.31―0.84%2.62%31.56%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%0%20%40%DE:7ATSE:MCOV.BSE:AMBEASE:CARESE:ASKERDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:7AT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:7ATAttendo AB11.404.0254.47%
SE:MCOV.BMedicover263.0025.9810.96%
SE:AMBEAAmbea AB195.5070.0055.78%
SE:CARECareium AB30.405.3021.12%
SE:ASKERAsker Healthcare Group AB74.40-17.37-18.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.